1. Academic Validation
  2. In vitro and in vivo activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphoma

In vitro and in vivo activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphoma

  • Haematologica. 2018 Nov;103(11):e537-e540. doi: 10.3324/haematol.2018.189241.
Montserrat Pérez-Salvia 1 Eneko Aldaba 2 Yosu Vara 2 Myriam Fabre 3 Cristina Ferrer 3 Carme Masdeu 4 Aizpea Zubia 5 Eider San Sebastian 5 Dorleta Otaegui 6 Pere Llinàs-Arias 1 Margalida Rosselló-Tortella 1 Maria Berdasco 1 Catia Moutinho 1 Fernando Setien 1 Alberto Villanueva 7 Eva González-Barca 8 Josep Muncunill 9 José-Tomás Navarro 9 Miguel A Piris 10 Fernando P Cossio 5 Manel Esteller 11 12 13 14
Affiliations

Affiliations

  • 1 Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL) L'Hospitalet, Barcelona, Catalonia.
  • 2 Quimatryx, San Sebastian.
  • 3 Oncomatryx, Arteaga Auzoa, 43, Derio.
  • 4 Department of Organic Chemistry I, Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), San Sebastián.
  • 5 Department of Organic Chemistry I, Centro de Innovación en Química Avanzada (ORFEO-CINQA), Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), Donostia International Physics Center (DIPC), San Sebastián.
  • 6 Mass Spectrometry Platform, CIC biomaGUNE, San Sebastian.
  • 7 Laboratory of Translational Research, Catalan Institute of Oncology (ICO), IDIBELL L'Hospitalet, Barcelona, Catalonia.
  • 8 Department of Hematology, ICO-Hospital Duran i Reynals, IDIBELL, University of Barcelona, L'Hospitalet, Barcelona, Catalonia.
  • 9 Department of Hematology, ICO-Hospital Universitari Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Catalonia.
  • 10 Pathology Service, Fundación Jiménez Díaz, Madrid.
  • 11 Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL) L'Hospitalet, Barcelona, Catalonia [email protected].
  • 12 Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid.
  • 13 Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), L'Hospitalet, Catalonia.
  • 14 Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.
Figures
Products